Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04823949 · ClinicalTrials.gov registry record · NA
Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring
A NA study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT04823949 is a NA study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 202 participants.
The verdict
NCT04823949, a NA study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
A large segment of our patient population is diagnosed with hypertensive disorders of pregnancy, including gestational hypertension and pre-eclampsia. New guidelines from the American College of Obstetricians and Gynecologists recommend postpartum monitoring of blood pressures via blood pressure checks on day 3 postpartum and between days 7-10 postpartum. Our purpose is to compare the effectiveness of using a Bluetooth-enabled home blood pressure monitoring platform to the standard postpartum office-based blood pressure monitoring in performing the recommended postpartum follow-up for patients with hypertensive disorders of pregnancy.
Interventions
- DEVICE Home blood pressure monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2022-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04823949
The ClinicalTrials.gov registry entry for NCT04823949 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Home blood pressure monitoring is the first listed.
NCT04823949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04823949 about?
NCT04823949 is a clinical study titled "Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring". A large segment of our patient population is diagnosed with hypertensive disorders of pregnancy, including gestational hypertension and pre-eclampsia. New guidelines from the American College of Obstetricians and Gynecologists recommend postpartum monitoring of blood pressures via blood pressure che...
What is the current status of trial NCT04823949?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2021-04-15. Estimated completion is 2022-01-18.
What interventions are being tested in trial NCT04823949?
The interventions under investigation include: Home blood pressure monitoring (DEVICE).
Who is sponsoring clinical trial NCT04823949?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.